
PD Dr. med.
Christian Garzoni
-
Formazione
- Laurea in medicina
- 1998
-
Specializzazione
- Medicina interna generale
- 2006
- Malattie infettive
- 2006
-
Ruolo
- Specialista in medicina interna generale e malattie infettive
- Medico accreditato
- Direttore sanitario
-
Affiliazioni
- Società svizzera medicina interna (SGIM)
- Società svizzera malattie infettive (SGInf)
- Swiss Transplantation Society
- Società europea di microbiologia clinica e malattie infettive (ESCMID)
- European society for organ transplantation (ESOT)
- American society of transplantations (ATS)
- The Transplantation Society (TTS)
- International Immunocompromised Host Society (ICHS)
-
Anno di nascita
- 1973
-
Inizio attività in clinica
- 2011
-
Contatto
- Per l’ospedalizzazione di un paziente o per richiedere documentazione medica
- T+ 41 91 960 87 12
- christian.garzoni@moncucco.ch
- segretariato.medico@moncucco.ch
-
Contatto studio privato
- Per fissare un appuntamento o contattare il medico
- Studi Medici Riuniti & Partners, Via Moncucco 23, 6900 Lugano
- T+ 41 91 261 38 00
-
Lingue
- Italiano
- Tedesco
- Francese
- Inglese
-
Esperienze professionali
- Capoclinica e responsabile per il servizio malattie infettive nei trapiantati, Divisione malattie infettive, Inselspital di Berna
- 2007 / 2011
- Capoclinica per il Pronto soccorso di medicina interna, Inselspital di Berna
- 2011
-
Altre attività
- Pratica di laboratorio
- Membro del comitato scientifico, Rivista Tribuna Medica Ticinese
- Membro di Comitato, Circolo medico di Lugano
- Membro di Comitato, Società Ticinese di Medicina Interna AMITI
- Membro nel gruppo di ricerca svizzero sulle infezioni nei trapiantati e responsabile per il Ticino, dal 2012
- Consulente di Swisstransplant e Organizzazione Mondiale Sanità (OMS/WHO) per infezioni nei donatori, dal 2011
- Libera docenza Università di Berna, dal 2007
- Responsabile dello Studio Svizzero di coorte dei trapianti, Inselspital di Berna, 2007 / 2011
- Medico aggiunto esterno per la clinica universitaria di medicina interna (KAIM), Inselspital di Berna dal 2011
Pubblicazioni
Golshayan D, Wójtowicz A, Bibert S, Pyndiah N, Manuel O, Binet I, Buhler LH, Huynh-Do U, Mueller T, Steiger J, Pascual M, Meylan P, Bochud PY; Swiss Transplant Cohort Study. Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation. Kidney Int. 2016 Apr;89(4):927-38.
Quteineh L, Bochud PY, Golshayan D, Crettol S, Venetz JP, Manuel O, Kutalik Z, Treyer A, Lehmann R, Mueller NJ, Binet I, van Delden C, Steiger J, Mohacsi P, Dufour JF, Soccal PM, Pascual M, Eap CB; and The Swiss Transplant Cohort Study. CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics J. 2015 Dec 8.
Agüero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C, Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F, Nishida S, Gastaca M, Miró JM; FIPSE/NIH HIVTR/NEAT023 Investigators. Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study. Am J Transplant. 2016 Feb;16:679-87
Berger C, Bochud PY, Boggian K, Cusini A, Egli A, Garzoni C, Hirsch HH, Hoffmann M, Khanna N, Manuel O, Meylan P, Nadal D, van Delden C, Weisser M, Mueller NJ; Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study. The Swiss Transplant Cohort Study: lessons from the first 6 years. Curr Infect Dis Rep. 2015 Jun;17:486
Wójtowicz A, Lecompte TD, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch H, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study.
Schmied L, Terszowski G, Gonzalez A, Schmitter K, Hirsch HH, Garzoni C, van Delden C, Boggian K, Mueller NJ, Berger C, Villard J, Manuel O, Meylan P, Hess C, Stern M; Swiss Transplant Cohort Study. Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes. Transplantation. 2015 Dec;99(12):2651-5.
Wójtowicz A, Lecompte TD, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study.
Manuel O, Wójtowicz A, Bibert S, Mueller NJ, van Delden C, Hirsch HH, Steiger J, Stern M, Egli A, Garzoni C, Binet I, Weisser M, Berger C, Cusini A, Meylan P, Pascual M, Bochud PY; Swiss Transplant Cohort Study.
Wójtowicz A, Gresnigt MS, Lecompte T, Bibert S, Manuel O, Joosten LA, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch HH, Weisser M, Mueller NJ, Meylan PR, Steiger J, Kutalik Z, Pascual M, van Delden C, van de Veerdonk FL, Bochud PY; Swiss Transplant Cohort Study (STCS); Swiss Transplant Cohort Study STCS. IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation. J Infect Dis. 2015 May 15;211(10):1646-57.
Berger C, Bochud PY, Boggian K, Cusini A, Egli A, Garzoni C, Hirsch HH, Hoffmann M, Khanna N, Manuel O, Meylan P, Nadal D, van Delden C, Weisser M, Mueller NJ; Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study. The swiss transplant cohort study: lessons from the first 6 years. Curr Infect Dis Rep. 2015 Jun;17(6):486
Wójtowicz A, Lecompte TD, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch H, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study (STCS); Swiss Transplant Cohort Study STCS. PTX3 Polymorphisms and Invasive Mold Infections after Solid Organ Transplantation. Clin Infect Dis. 2015 May 14.
Gonzalez A, Schmitter K, Hirsch HH, Garzoni C, van Delden C, Boggian K, Mueller NJ, Berger C, Villard J, Manuel O, Meylan P, Stern M, Hess C; Swiss Transplant Cohort Study. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients. Genes Immun. 2014 Oct;15(7):495-9
Garzoni C, Uçkay I, Belaieff W, Breilh D, Suvà D, Huggler E, Lew D, Hoffmeyer P, Bernard L. In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study. Springerplus. 2014 Jun 7;3:287.
Len O*, Garzoni C*, Lumbreras C, Molina I, Meije Y, Pahissa A, Grossi P; The ESCMID Study Group of Infection in Compromised Hosts (ESGICH).*contributed equally. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect. 2014
Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss Transplant Cohort Study. Bucheli E, Kralidis G, Boggian K, Cusini A, Garzoni C, Manuel O, Meylan PR, Mueller NJ, Khanna N, van Delden C, Berger C, Koller MT, Weisser M; Swiss Transplant Cohort Study. Transpl Infect Dis. 2014 Feb;16(1):26-36
Microbial communities in the respiratory tract of patients with interstitial lung disease. Garzoni C, Brugger SD, Qi W, Wasmer S, Cusini A, Dumont P, Gorgievski-Hrisoho M, Mühlemann K, von Garnier C, Hilty M. Thorax. 2013 Dec;68:1150-6
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. Manuel O, Kralidis G, Mueller NJ, Hirsch HH, Garzoni C, van Delden C, Berger C, Boggian K, Cusini A, Koller MT, Weisser M, Pascual M, Meylan PR; Swiss Transplant Cohort Study.
Garzoni C, Vergidis P; AST Infectious Diseases Community of Practice. Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections in solid organ transplantation. Am J Transplant. 2013 Mar;13 Suppl 4:50-8
Berger C, Boggian K, Cusini A, van Delden C, Garzoni C, Hirsch HH, Khanna N, Koller M, Manuel O, Meylan P, Nadal D, Weisser M, Mueller NJ; Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study. Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant. 2012 Dec;17:581-5
Zürcher S, Mooser C, Lüthi AU, Mühlemann K, Barbani MT, Mohacsi P, Garzoni C, Gorgievski-Hrisoho MSchaller A, Flatz L. Sensitive and rapid detection of ganciclovir resistance by PCR based MALDI-TOF analysis. J Clin Virol. 2012;54:359-63
Berger C, Boggian K, Cusini A, van Delden C, Garzoni C, Hirsch HH, Khanna N, Koller M, Manuel O, Meylan P, Nadal D, Weisser M, Mueller NJ; Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study. Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant. 2012 Dec;17:581-585.
Engler K, Mühlemann K, Garzoni C, Pfahler H, Geiser T, von Garnier Ch. Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients. Swiss Med Wkly Swiss Med Wkly. 2012;30:142
Garzoni C, Müller NJ. Infections in solid organ transplantation - prophylaxis, diagnostic approach and therapy. Ther Umsch. 2011 Dec;68(12):735-43.
Garzoni C, Ison M. Uniform Definitions for Donor-Derived Infectious Disease Transmissions in Solid Organ Transplantation. Transplantation. 2011;92:1297-300
Muhlethaler K, Bogli-Stuber K, Wasmer S, von Garnier Ch, Dumont Ph, Rauch A, Muhlemann K, Garzoni C*. Quantitative PCR to diagnose pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Resp J 2011
Babouee B, Widmer A, Dubuis O, Ciardo D, Droz S, Betsch B, Garzoni C, Fuhrer U, Battegay M, Frei R, Goldenberger D. 1.Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10. Euro Surveill. 2011; 17;16.
Garzoni C, Kelley WL Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus. EMBO Molecular Medicine. 2011 EMBO Mol Med. 2011;3:115-7.
Scherrer AU, von Wyl V, Böni J, Yerly S, Klimkait T, Bürgisser P, Garzoni C, Hirschel B, Cavassini M, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF; and the Swiss HIV Cohort Study (SHCS). Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. J Acquir Immune Defic Syndr. 2011; 57 :24-31.
Uçkay I, Garzoni C, Ferry T, Harbarth S, Stern R, Assal M, Hoffmeyer P, Lew D, Bernard L. Postoperative serum Pro-Calcitonin and C-reactive protein levels in patients with orthopedic infections. Swiss Med Wkly 2010 Nov 19;140: w13124
Bernard L, Assal M, Garzoni C, Uçkay I. Predicting the pathogen of diabetic toe osteomyelitis by two consecutive ulcer cultures with bone contact. Eur J Clin Microbiol Infect Dis. 2011 ; 30: 279-81.